By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ProNAi Therapeutics, Inc. 

4717 Campus Drive
Suite 1100
Kalamazoo  Michigan  49008  U.S.A.
Phone: 269-372-3289 Fax: 269-544-1079


Company News
ProNAi Therapeutics, Inc. Reports Second Quarter 2015 Results 8/21/2015 6:55:58 AM
ProNAi Therapeutics, Inc. Announces Closing Of IPO And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 7/22/2015 10:06:01 AM
ProNAi Therapeutics, Inc. Announces Pricing Of Initial Public Offering 7/16/2015 7:26:21 AM
ProNAi Therapeutics, Inc. Appoints Dr. Barbara Klencke As Chief Development Officer 6/23/2015 6:37:18 AM
ProNAi Therapeutics, Inc. Appoints Dr. Nicole Onetto And Mr. Robert Pelzer To Its Board Of Directors 6/18/2015 6:21:46 AM
ProNAi Therapeutics, Inc. Strengthens Leadership Team; Opens Vancouver Corporate Headquarters 6/16/2015 6:15:13 AM
ProNAi Therapeutics, Inc. Files Registration Statement For Proposed Initial Public Offering 6/15/2015 6:37:45 AM
ProNAi Therapeutics, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/13/2015 9:32:05 AM
ProNAi Therapeutics, Inc. Initiates Phase 2 Trial Of PNT2258 In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) 1/7/2015 8:49:54 AM
Marina Biotech, Inc. (MRNA) Reports That Licensee ProNAi Therapeutics, Inc. Presented Interim Phase 2 Data On Its BCL2-Targeting DNAi® Therapeutic At American Society of Hematology 2014 12/10/2014 11:25:37 AM